LWAM
VRTX icon

Legacy Wealth Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Legacy Wealth Asset Management’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.33M Buy
2,553
+1,057
+71% +$541K 0.29% 94
2026
Q2 		$743K Buy
1,496
+1
+0.1% +$443 0.16% 194
2026
Q1 		$668K Buy
1,495
+12
+0.8% +$5.6K 0.16% 212
2025
Q4 		$672K Buy
1,483
+41
+3% +$17.7K 0.17% 200
2025
Q3 		$565K Buy
1,442
+26
+2% +$10.9K 0.14% 236
2025
Q2 		$630K Sell
1,416
-13
-0.9% -$5.99K 0.16% 202
2025
Q1 		$693K Sell
1,429
-22
-2% -$10.3K 0.19% 164
2024
Q4 		$584K Sell
1,451
-7
-0.5% -$3.25K 0.16% 206
2024
Q3 		$678K Buy
1,458
+12
+0.8% +$5.76K 0.18% 181
2024
Q2 		$678K Sell
1,446
-2,938
-67% -$1.28M 0.19% 154
2024
Q1 		$1.83M Sell
4,384
-8
-0.2% -$3.38K 0.51% 49
2023
Q4 		$1.79M Sell
4,392
-12
-0.3% -$4.43K 0.59% 45
2023
Q3 		$1.53M Buy
4,404
+17
+0.4% +$5.95K 0.56% 48
2023
Q2 		$1.54M Buy
4,387
+1,164
+36% +$392K 0.54% 45
2023
Q1 		$1.02M Buy
3,223
+8
+0.2% +$2.4K 0.37% 76
2022
Q4 		$928K Buy
3,215
+6
+0.2% +$1.83K 0.35% 85
2022
Q3 		$929K Buy
+3,209
New +$923K 0.41% 75

Other funds holding VRTX

DC
Davenport & Co Richmond, Virginia $19.9B AUM 12.67% 1-Year Est. Return
MBI
Montrusco Bolton Investments Montreal, Quebec, Canada $5.77B AUM 24.61% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return
GIA
Gateway Investment Advisers Cincinnati, Ohio $11B AUM 34.31% 1-Year Est. Return
II
IFM Investors Melbourne, Australia $16B AUM 33.69% 1-Year Est. Return
MLL
Moody Lynn & Lieberson Boston, Massachusetts $1.93B AUM 20.85% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.95B AUM 16% 1-Year Est. Return
VWM
Valley Wealth Managers Paramus, New Jersey $1.76B AUM 33.82% 1-Year Est. Return
BIAS
Beacon Investment Advisory Services Morristown, New Jersey $2.66B AUM 29.77% 1-Year Est. Return

Legacy Wealth Asset Management's VRTX Position: Q3 2026 in Review

Legacy Wealth Asset Management increased its Vertex Pharmaceuticals (VRTX) stake by 71% in Q3 2026, buying an estimated $541K and bringing the position to 2,553 shares worth $1.33M. The position accounts for 0.29% of the portfolio, ranked #94.

Legacy Wealth Asset Management first reported a position in VRTX in Q3 2022 and has held it in 17 quarters since. The position peaked at $1.83M in Q1 2024. 165 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.

  • Legacy Wealth Asset Management held 2,553 shares of Vertex Pharmaceuticals worth $1.33M as of Q3 2026.
  • Legacy Wealth Asset Management bought 1,057 Vertex Pharmaceuticals shares in Q3 2026, an estimated $541K.
  • Vertex Pharmaceuticals made up 0.29% of Legacy Wealth Asset Management's portfolio in Q3 2026, its #94 holding.
  • Legacy Wealth Asset Management first reported a position in Vertex Pharmaceuticals in Q3 2022 and has held it in 17 quarters since.
  • Legacy Wealth Asset Management's Vertex Pharmaceuticals position peaked at $1.83M in Q1 2024.
  • 165 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.

Based on Legacy Wealth Asset Management's 13F filing for Q3 2026, filed 9 Oct 2026.